OncoCyte Corp (NAS:OCX)
$ 2.435 -0.095 (-3.75%) Market Cap: 40.99 Mil Enterprise Value: 43.22 Mil PE Ratio: 0 PB Ratio: 3.34 GF Score: 31/100

OncoCyte Corp Investor and Analyst Day Transcript

Dec 14, 2021 / 07:30PM GMT
Release Date Price: $43 (-1.83%)
Operator

Good afternoon, and welcome to the OncoCyte Business Update Call. (Operator Instructions) It is important to management that they address as many questions as possible. In an effort to make sure we have enough time to do so, please submit any questions you may have towards the beginning of the meeting, by using the Q&A text box at the bottom of the webcast player or by e-mailing your questions to questions at lifesciadvisors.com. As a reminder, this webinar is being recorded, and a replay will be made available on the OncoCyte website following the conclusion of the event.

I'd now like to turn the call over to your host, Ronnie Andrews, President and CEO of OncoCyte. Please go ahead, Ronnie.

Ronald A. Andrews
OncoCyte Corporation - CEO, President & Director

Tara, thank you, and thanks, everyone, for joining today. As mentioned on, we're out traveling in the summer and the fall meeting with investors and different groups at different meetings. It became apparent that many of you had questions about a lot of the announcements we're making, how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot